Particle.news

Download on the App Store

Estrogen Spurs Podocyte Renewal, Linking Female Kidney Resilience to Preeclampsia

The study pinpoints estrogen receptor signaling in renal progenitors as the driver of podocyte renewal with translational potential for CKD, preeclampsia.

Overview

  • Researchers report in Science that female mice regenerate more podocytes via estrogen-regulated renal progenitor cells, offering a mechanistic basis for lower CKD risk during reproductive years.
  • The female advantage emerged after puberty, and deleting estrogen receptors in renal progenitors erased this benefit, dropping podocyte generation to male-like levels.
  • During pregnancy, estrogen-driven activation of renal progenitors increased podocyte production to meet higher filtration demands.
  • Disrupting this program produced preeclampsia-like disease in mice and led to offspring with lower kidney mass and fewer filtering units, increasing later-life renal vulnerability.
  • Human support came from finding renal progenitor cells in the urine of pregnant women that differentiated into podocytes in vitro, though clinical validation and therapeutic development remain outstanding.